A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine

NCT06578585 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Ubrogepant
DRUG: Lu AG09222
DRUG: Placebo

Sponsor

H. Lundbeck A/S